首页> 美国卫生研究院文献>Neuro-Oncology >PDTM-03. CHICKEN EMBRYO CHORIOALLANTOIC MEMBRANE (CAM) ASSAY AS A XENOGRAFT MODEL FOR TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS
【2h】

PDTM-03. CHICKEN EMBRYO CHORIOALLANTOIC MEMBRANE (CAM) ASSAY AS A XENOGRAFT MODEL FOR TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS

机译:PDTM-03。鸡胚绒毛膜膜(CAM)测定作为异种移植模型用于治疗弥漫性内在猪胶质瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diffuse intrinsic pontine gliomas (DIPG), known today as diffuse midline gliomas with the H3K27M mutation, are inoperable and aggressive brain tumors found predominantly in children. Despite extensive research no treatment or cure has been elucidated. Studies in 2012 showed that the majority of DIPG tumors have the H3K27M mutation, but the development of novel therapeutics has been hindered by lack of good laboratory models. Although patient derived cell lines with the H3K27M mutation have increased, the development of good murine xenografts are lagging, requiring extensive time and money. Previous studies have shown that the chicken embryo Chorioallantoic Membrane (CAM) model is an affordable and time-efficient method of studying tumor biology and response to treatment. We sought to develop this in H3K27M tumors to bridge the gap between in vitro—in vivo studies.
机译:今天已知的弥漫性内在猪胶石(DIPG),如弥漫性中线胶质瘤,与H3K27M突变差异,是不可操作和主要在儿童的侵袭性脑肿瘤。尽管采用广泛的研究,但没有阐明治疗或治疗方法。 2012年的研究表明,大多数DIPG肿瘤都有H3K27M突变,但新的治疗方法的发展已经受到缺乏良好的实验室模型。虽然患者衍生的细胞系具有H3K27M突变的突变,但是良好的小鼠异种移植物的发育是滞后的,需要广泛的时间和金钱。以前的研究表明,鸡胚型血管膜膜(CAM)模型是研究肿瘤生物学和治疗反应的实惠且时间有效的方法。我们试图在H3K27M肿瘤中发展这一点,以弥合体外体内研究之间的差距。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号